From: Human papillomavirus DNA in plasma of patients with cervical cancer
 |  | Total | Plasma HPV DNA | ||
---|---|---|---|---|---|
 |  |  | Positive |  | Negative |
Cervical Cancer patient | 50 | 6 | Â | 44 | |
Agea | Â | Â | Â | Â | Â |
 | <50 | 25 | 3 |  | 22 |
 | >50 | 25 | 3 |  | 22 |
HPV type | Â | Â | Â | Â | Â |
 | Ub | 4 | 0 |  | 4 |
 | 16 | 28 | 2 |  | 26 |
 | 18 | 16 | 4 |  | 12 |
 | 33 | 2 | 0 |  | 2 |
Stage | Â | Â | Â | Â | Â |
 | IB | 2 | 0 |  | 2 |
 | IIB | 17 | 3 |  | 14 |
 | IIIB | 28 | 0 |  | 28 |
 | IVB | 1 | 1 |  | 0 |
 | Rc | 2 | 2 |  | 0 |
IIB response to radiotherapy | Â | Â | Â | Â | |
 | PRd | 3 | 2 |  | 1 |
 | CRe | 15 | 1 |  | 13 |
IIB clinical outcome within | Â | Â | Â | Â | |
one year after complete | Â | Â | Â | Â | |
treatment | Â | Â | Â | Â | |
Rc | Â | 6 | 2 | Â | 4 |
NEDf | Â | 5 | 0 | Â | 5 |
Metastases | Â | Â | Â | Â | |
 | Positive | 3 | 3 | P = 0001 | 0 |
 | Negative | 47 | 3 | RR = 15.67 | 44 |
Histopathology type | Â | Â | Â | Â | |
 | Squamous | 42 | 5 |  | 37 |
 | Adenomatous | 8 | 1 |  | 7 |